KEY Investment Partners
1550 Larimer Street, Suite 1084, Denver, Colorado, 80202, United States
Overview
Equity investment for early-stage companies.
Founded
2018
Deals ยท 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Katalys | Sep 2023Participated | $5 MSeed | |
Mr. Moxey's Mints | Jul 2023Led | $9 MSeries B | |
FarmaceuticalRx | Aug 2022Led | $2 MOther Equity | |
Flywheel | Sep 2021Participated | $22 MSeries C | |
Open Book Extracts | Jun 2021Led | $12 MSeries B | |
Rev Ventures Group | Mar 2021Led | $1 MSeed | |
Front Range Biosciences | Aug 2020Led | $30 MSeries B | |
springbig | Aug 2020Participated | $12 MSeries B | |
BDSA | Aug 2019Led | $7 MOther Equity | |
Katalys | Sep 2023Participated | $5 MSeed | |
Mr. Moxey's Mints | Jul 2023Led | $9 MSeries B | |
FarmaceuticalRx | Aug 2022Led | $2 MOther Equity | |
Flywheel | Sep 2021Participated | $22 MSeries C | |
Open Book Extracts | Jun 2021Led | $12 MSeries B | |
Rev Ventures Group | Mar 2021Led | $1 MSeed | |
Front Range Biosciences | Aug 2020Led | $30 MSeries B | |
springbig | Aug 2020Participated | $12 MSeries B | |
BDSA | Aug 2019Led | $7 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 1 |
| Series B | 3 | 1 |
| Series C+ | 0 | 1 |
| Other Equity | 2 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Aug '19 | 1 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 2 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Marketing & Advertising | 4 |
| Enterprise Software | 2 |
| Data, Analytics & IT | 2 |
| Networks, Cloud & Communication | 2 |
| Food & Agriculture | 2 |
| Education & Workforce | 1 |
| Government & Defense | 1 |
| E-Commerce & Retail | 1 |
| Real Estate & Construction | 1 |
| Consumer & Lifestyle | 1 |
| Fintech | 1 |
| Manufacturing | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 3 |
| $10M-$25M | 3 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Argonautic Ventures | 2 |
| GreenAxs Capital | 2 |
| 7thirty Capital | 1 |
| 8VC | 1 |
| AFI Capital Partners | 1 |
| Altitude Investment Management | 1 |
| Beringea | 1 |
| Entourage Effect Capital | 1 |
| Great North Ventures | 1 |
| Halley Venture Partners | 1 |
| Hewlett Packard Pathfinder | 1 |
| iSelect | 1 |
| Norte Capital | 1 |
| Novartis dRx | 1 |
| Phyto Partners | 1 |
| Salex Capital | 1 |
| Seraph Group | 1 |
| Spike Ventures | 1 |
| TVC Capital | 1 |
| WGD Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 67% |
| Participating | 3 | 33% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 50% |
| Co-led | 3 | 50% |